Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2019Diabetes/Metabolism Research and Reviews

Osteocalcin and sclerostin: Background characters or main actors in cardiovascular disease?

View Full Paper
Ask AI
Bookmark
Share

Authors

LDLuca D’OnofrioEMErnesto MaddaloniRBRaffaella Buzzetti

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

D’Onofrio et al. (2019) studied this question.

synapsesocial.com/papers/6aaa22dcdf35e3fdba8449a3https://doi.org/10.1002/dmrr.3217
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Osteocalcin, Vascular Calcification, and Atherosclerosis: A Systematic Review and Meta-analysis2017 · 72 citations
  2. 2Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis2017 · 1,539 citations
  3. 3A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis2018 · 329 citations
  4. 4Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels2013 · 133 citations
  5. 5Potential Role for Osteocalcin in the Development of Atherosclerosis and Blood Vessel Disease2018 · 64 citations